KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

New York Times (NYT) Cash & Equivalents (2016 - 2025)

New York Times' Cash & Equivalents history spans 17 years, with the latest figure at $255.4 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 28.08% year-over-year to $255.4 million; the TTM value through Dec 2025 reached $255.4 million, up 28.08%, while the annual FY2025 figure was $255.4 million, 28.08% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $255.4 million at New York Times, up from $249.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $324.0 million in Q3 2021 and bottomed at $161.3 million in Q2 2022.
  • The 5-year median for Cash & Equivalents is $229.1 million (2023), against an average of $235.4 million.
  • The largest annual shift saw Cash & Equivalents tumbled 49.72% in 2022 before it soared 52.24% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $320.0 million in 2021, then crashed by 30.81% to $221.4 million in 2022, then surged by 30.76% to $289.5 million in 2023, then plummeted by 31.1% to $199.4 million in 2024, then grew by 28.08% to $255.4 million in 2025.
  • Per Business Quant, the three most recent readings for NYT's Cash & Equivalents are $255.4 million (Q4 2025), $249.3 million (Q3 2025), and $198.2 million (Q2 2025).